Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 delta pseudogene 5 (EEF1DP5)

Target: EEF1DP5
Molecular classification: Other (Pseudogene)

Overview

EEF1DP5 (eukaryotic translation elongation factor 1 delta pseudogene 5) is a human **pseudogene** related to the functional EEF1D gene family, which in turn encodes a component of the translation elongation factor complex involved in protein synthesis. However, EEF1DP5 itself does not encode a functional protein and has no established cellular or physiological role[3]. Pseudogenes like EEF1DP5 generally arise from gene duplication or mutation and are usually nonfunctional remnants within the genome.

Other names: Eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) pseudogeneEEF1DP5

Mechanism of action

None. No therapeutic mechanism or drug action is associated with EEF1DP5.

Biological functions

None established. Pseudogenes, by definition, do not encode active proteins and lack direct, defined biological function[3].

Disease associations

None established. There is no evidence that EEF1DP5 is directly implicated in any disease, nor is there indication of its use as a disease biomarker or involvement in disease pathways.

Safety considerations

None described. There are no safety or therapeutic challenges known to be associated with this pseudogene.

Interacting drugs

None. As a pseudogene, EEF1DP5 does not produce an active protein with which drugs would interact.

Biomarkers

None. EEF1DP5 is not currently recognized as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 delta pseudogene 5 (EEF1DP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 delta pseudogene 5 (EEF1DP5).

Explore the full profile